Cite
HARVARD Citation
Khashab, T. et al. (2019). Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma. British journal of haematology. pp. 670-678. [Online].